Jefferies & Co Has Just Reaffirmed $48.00 Target Price Per Share on Chemours Company (NYSE:CC) stock, While They’ve Also Reiterated Their “Buy” Rating

June 19, 2017 - By Marry Poplack

 Jefferies & Co Has Just Reaffirmed $48.00 Target Price Per Share on Chemours Company (NYSE:CC) stock, While They’ve Also Reiterated Their

Chemours Company (NYSE:CC) Rating Reaffirmed

They currently have a $48.00 target price per share on Chemours Company (NYSE:CC). The target price by Jefferies & Co would suggest a potential upside of 30.79 % from the company’s close price. This has been disclosed to clients in analysts report on Friday, 16 June.

Chemours Co (NYSE:CC) Ratings Coverage

Among 8 analysts covering Chemours (NYSE:CC), 6 have Buy rating, 1 Sell and 1 Hold. Therefore 75% are positive. Chemours has $55 highest and $5.25 lowest target. $23.88’s average target is -36.23% below currents $37.45 stock price. Chemours had 23 analyst reports since July 27, 2015 according to SRatingsIntel. Citigroup maintained Chemours Co (NYSE:CC) on Thursday, August 11 with “Neutral” rating. Jefferies maintained Chemours Co (NYSE:CC) rating on Thursday, September 1. Jefferies has “Hold” rating and $15 target. As per Tuesday, February 16, the company rating was downgraded by Jefferies. The firm earned “Positive” rating on Monday, May 15 by Susquehanna. UBS maintained Chemours Co (NYSE:CC) rating on Tuesday, August 9. UBS has “Sell” rating and $5.25 target. The rating was maintained by Citigroup on Monday, April 18 with “Neutral”. Susquehanna initiated it with “Neutral” rating and $13 target in Monday, July 27 report. The firm has “Hold” rating given on Friday, September 18 by Argus Research. The stock of Chemours Co (NYSE:CC) has “Buy” rating given on Wednesday, March 29 by Jefferies. The firm has “Overweight” rating by JP Morgan given on Friday, May 12.

About 956,934 shares traded. Chemours Co (NYSE:CC) has risen 327.71% since June 19, 2016 and is uptrending. It has outperformed by 311.01% the S&P500.

Wall Street await Chemours Co (NYSE:CC) to release earnings on August, 14. Analysts forecast EPS of $0.71, up exactly $0.44 or 162.96 % from 2014’s $0.27 EPS. The expected CC’s profit could reach $129.87M giving the stock 13.19 P/E in the case that $0.71 earnings per share is reported. After posting $0.75 EPS for the previous quarter, Chemours Co’s analysts now forecast -5.33 % negative EPS growth.

The Chemours Company is a provider of performance chemicals. The company has market cap of $6.85 billion. The Firm operates through three divisions: Titanium Technologies, Fluoroproducts and Chemical Solutions. It has a 69.03 P/E ratio. The Titanium Technologies segment is a producer of titanium dioxide .

More notable recent Chemours Co (NYSE:CC) news were published by: Reuters.com which released: “BRIEF-Chemours Co reports offering of $500 mlnof senior notes” on May 09, 2017, also Prnewswire.com with their article: “The Chemours Company Announces Completion of $500000000 of 5.375% Senior Notes …” published on May 23, 2017, Prnewswire.com published: “The Chemours Company Announces Offering of $500000000 of Senior Notes Due 2027” on May 09, 2017. More interesting news about Chemours Co (NYSE:CC) were released by: Reuters.com and their article: “BRIEF-Chemours Co files for offering of $500 million of senior notes due 2027” published on May 09, 2017 as well as Investorplace.com‘s news article titled: “Others Overlooked Chemours Co (CC) Stock: Should You Buy It Now?” with publication date: June 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.